Leucinamide hydrochloride → Isobutyl (4S)-4-isobutyl-5-oxo-2-imidazolidinepropanoate

HRID 1589807

반응식

HRID 1589807 반응식
Cl.[NH2:2][C@H:3]([C:8]([NH2:10])=[O:9])[CH2:4][CH:5]([CH3:7])[CH3:6].O=[CH:12][CH2:13][CH2:14][C:15]([O:17][CH2:18][CH:19]([CH3:21])[CH3:20])=[O:16]>>[CH2:4]([C@H:3]1[C:8](=[O:9])[NH:10][CH:12]([CH2:13][CH2:14][C:15]([O:17][CH2:18][CH:19]([CH3:21])[CH3:20])=[O:16])[NH:2]1)[CH:5]([CH3:7])[CH3:6]

참가 물질

3

실험 절차

L-Leucinamide hydrochloride (3.2 g, 19.2 mmol) and isobutyl 4-oxobutanoate (3 g, 18.96 mmol) were reacted together according to the procedure of example 5A to give the title compound, 1.7 g (33%).

출처 및 근거

ORD 기록
ord-82afd3c832574553a3cde10a5a8fa0e6
출처 데이터셋
uspto-grants-1993_04
특허 번호
US05200406

연결된 노트

불러오는 중…